ASCO Guidelines
by American Society of Clinical Oncology (ASCO)
Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage…
About this podcast
ASCO Guidelines Podcast breaks down pivotal recommendations from the latest evidence-based clinical practice guidance and provides insight into daily patient care. Listen to stay up to date with the ever-evolving landscape of cancer research and treatment.
Episodes
The newest 20 of 203 episodes
- Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline 2026.1.0 · 14 minDr. Jennifer Caswell-Jin and Dr. Michael Hassett join the podcast to introduce the new living guideline, "Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III…
- Breast Cancer Follow-Up and Surveillance After Primary Treatment Guideline Update · 20 minDrs. Zeina Nahleh and Maryam Lustberg join the podcast to discuss the updated ASCO guideline on breast cancer follow-up and surveillance after primary treatment. Drs. Nahleh and…
- Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline 2026.1.0 · 21 minDrs. Jamie Lesnock and Sara Bouberhan join the podcast to discuss the first ASCO guideline on systemic treatment for recurrent ovarian cancer. They provide a comprehensive…
- Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.2 · 9 minDr. Sonam Puri joins the podcast to share the update to the living guideline on stage IV NSCLC with driver alterations. Dr. Puri discusses the practice-changing evidence reviewed…
- Treatment of Multiple Myeloma: ASCO Living Guideline Update 2026.1.1 · 18 minDr. Rahul Banerjee joins the podcast to discuss the latest update to the living guideline on the treatment of multiple myeloma. He explains how sensational results from the…
- Circulating Tumor DNA Testing in Solid Tumors and Lymphoma Guideline · 18 minDrs. Tina Lockwood and Stacy Gray share the newly released evidence-based guideline on circulating tumor DNA (ctDNA) testing from ASCO. They highlight recommendations on when…
- Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 2 · 19 minDr. Joshua Reuss returns to the podcast to discuss the update to the living guideline on stage IV NSCLC with driver alterations. The conversation focuses on new cancer treatment…
- Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.1 Part 1 · 13 minDr. Lyudmila Bazhenova joins the podcast to share the update to the living guideline on stage IV NSCLC without driver alterations. Dr. Bazhenova discusses the evidence reviewed…
- Systemic Treatment of Thyroid Cancer Guideline · 23 minDr. Nabil Saba shares the first evidence-based guideline on thyroid cancer from ASCO. He highlights recommendations on first- and subsequent-line systemic treatment – including…
- Patient-Clinician Communication Guideline Update · 31 minDr. Timothy Gilligan and Dr. Calvin Chou discuss the updated guideline on patient-clinician communication in oncology. They highlight clinical recommendations and strategies on…
- Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancer Guideline Update · 29 minDr. Lakshmi Rajdev and Dr. Manish Shah join the podcast to discuss the updated guideline on immunotherapy and targeted therapy in unresectable locally advanced, advanced, or…
- White Blood Cell Growth Factors Guideline Update · 23 minDr. Bishal Gyawali and Dr. Tessa Cigler share the new, comprehensive, evidence-based update of the ASCO guideline on the use of hematopoietic colony-stimulating factors in…
- Therapy for Stage IV NSCLC With Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 2 · 20 minDr. Sonam Puri discusses the full update to the living guideline on stage IV NSCLC with driver alterations. She shares a new overarching recommendation on biomarking testing and…
- Therapy for Stage IV NSCLC Without Driver Alterations: ASCO Living Guideline Update 2026.3.0 Part 1 · 18 minDr. Joshua Reuss is back on the podcast to discuss the full update to the living guideline on stage IV NSCLC without driver alterations. He discusses the new evidence and how…
- Systemic Therapy in Patients With mCRPC: ASCO Living Guideline 2026.1 · 14 minDr. Mary-Ellen Taplin joins the podcast to discuss the latest changes to the living guideline on metastatic castration-resistant prostate cancer (mCRPC). She reviews new…
- Treatment of Multiple Myeloma: ASCO-OH (CCO) Living Guideline · 22 minDr. Lisa Hicks and Dr. Joseph Mikhael discuss the updated guideline from ASCO and Ontario Health (Cancer Care Ontario) on the treatment of multiple myeloma. They cover…
- Management of Cancer During Pregnancy Guideline · 35 minDr. Alison Loren and Dr. Ann Partridge share the latest guideline from ASCO on the management of cancer during pregnancy. They highlight the importance of this multidisciplinary…
- Management of Antineoplastic Extravasation: ONS-ASCO Guideline · 13 minDr. Tanya Thomas and Dr. Aparna Jotwani join the podcast to discuss the new Oncology Nursing Society and American Society of Clinical Oncology evidence-based guideline on the…
- Postmastectomy Radiation Therapy: ASTRO-ASCO-SSO Guideline · 16 minDr. Kathleen Horst, Dr. Rachel Jimenez, and Dr. Yara Abdou discuss the updated guideline from ASTRO, ASCO, and SSO on postmastectomy radiation therapy. They share new and updated…
- Geriatric Assessment Global Guideline · 16 minDr. Cris Bergerot and Dr. Enrique Soto join the podcast to discuss the new global guideline on geriatric assessment. This guideline provides evidence-based, resource-stratified…








